ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018
Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression.
Open access · bronzeAbstract read
In one paragraph
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 33 citations in OpenAlex.
- Improved Methods for the Stable Generation of Human Papillomavirus-Driven Head and Neck Cancer Cell Lines.Molecular carcinogenesis · 2025Article
- Understanding the Role of Rho GTPase Activating Protein and Bone Marrow Kinase X: A Novel Target in Gastric Cancer Treatment.Asian Pacific journal of cancer prevention : APJCP · 2025Review
- Characterization of uniquely tumorigenic cancer stem cells in salivary gland adenoid cystic carcinoma.Frontiers in oral health · 2025Article
- Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.Oral oncology · 2023Article
- Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials.iScience · 2023Article
- Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.Cellular oncology (Dordrecht, Netherlands) · 2023Article
- The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression.Life (Basel, Switzerland) · 2023Review
- Advances and Challenges in Cancer Stem Cells for Onco-Therapeutics.Stem cells international · 2023Review
- Bmi-1: A master regulator of head and neck cancer stemness.Frontiers in oral health · 2023Review
- An organoid library of salivary gland tumors reveals subtype-specific characteristics and biomarkers.Journal of experimental & clinical cancer research : CR · 2022Article
- p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022Article
- Article
- Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.Oral oncology · 2021Article
- Systemic therapies for salivary gland adenoid cystic carcinoma.American journal of cancer research · 2021Review
- Establishment of patient-derived xenograft models of adenoid cystic carcinoma to assess pre-clinical efficacy of combination therapy of a PI3K inhibitor and retinoic acid.American journal of cancer research · 2021Article
- Article
- Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation.EBioMedicine · 2019Article
- BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK/STAT3 signaling pathway.Cancer cell international · 2019Article
- p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy.Critical reviews in oncogenesis · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 3 institutions in 1 country.
Stephen B Keysar *Division of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
Justin R Eagles *Division of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
Bettina MillerDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
Brian C JacksonDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
Farshad N ChowdhuryDepartment of Otolaryngology, UCDSOM, Denver, Colorado.
Julie ReisingerDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.ORCID 0000-0003-3446-7277
Tugs-Saikhan ChimedDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
Phuong N LeDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
John J MortonDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
Hilary L SomersetDepartment of Pathology, UCDSOM, Denver, Colorado.
Marileila Varella-GarciaDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
Aik-Choon TanDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
John I SongDepartment of Otolaryngology, UCDSOM, Denver, Colorado.
Daniel W BowlesDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado.
Mary E ReylandDepartment of Craniofacial Biology, University of Colorado Denver School of Dental Medicine, Denver, Colorado.
Antonio JimenoDivision of Medical Oncology, Department of Medicine, University of Colorado Denver School of Medicine (UCDSOM), Denver, Colorado. Antonio.Jimeno@ucdenver.edu.
University of Colorado Denver · USCenter for Neuroscience and Regenerative Medicine · USColorado School of Public Health · US
Funding
University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0MTargeting PD-L1 interactome signaling to enhance immunotherapy efficacy in head and neck squamous cell cancerR01CA149456 · NCI · UNIVERSITY OF COLORADO DENVER · PI Antonio Jimeno · 2010 to 2026
$5.6MRegulation of Salivary Cell Apoptosis by Protein Kinase CR01DE015648 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI REYLAND, MARY ELAINE · 2004 to 2019
$5.6MInstitutional Training in Otolaryngology ResearchT32DC012280 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI Yuri Agrawal, Sue C. Kinnamon · 2013 to 2026
$3.4MIdentifying oral cancer stem cell properties affected by the microenvironmentR01DE024371 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI JIMENO, ANTONIO, WANG, XIAO-JING · 2014 to 2017
$2.1MDevelopment of an autologous humanized model of melanoma exploring human thymic education capacityR01CA213102 · NCI · UNIVERSITY OF COLORADO DENVER · PI JIMENO, ANTONIO · 2017 to 2019
$1.7MRational generation of a head and neck squamous cell cancer direct xenograft modeR21DE019712 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI JIMENO, ANTONIO · 2009 to 2010
$385k: Regulation of the cancer stem cell phenotype in salivary gland cancersR03DE027433 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI KEYSAR, STEPHEN B. · 2018 to 2019
$311kFunctional characterization of salivary gland cancers and development of patientR56DE023245 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI JIMENO, ANTONIO, REYLAND, MARY ELAINE · 2012 to 2012
$245kNCI NIH HHS P30 CA046934NCI NIH HHS R01 CA149456NCI NIH HHS R01 CA213102NIDCD NIH HHS T32 DC012280NIDCR NIH HHS R01 DE015648NIDCR NIH HHS R01 DE024371NIDCR NIH HHS R03 DE027433NIDCR NIH HHS R21 DE019712NIDCR NIH HHS R56 DE023245
Abstract
PubMed holds no abstract for this paper.
Indexed as
Biomarkers, TumorGene Expression Regulation, NeoplasticAnimalsCarcinogenesisCell Line, TumorDisease Models, AnimalDisease ProgressionExome SequencingGene Expression ProfilingHumansImmunohistochemistryImmunophenotypingMiceMutationNeoplastic Stem CellsRecurrenceBiomarkers, Tumor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.